Forum for Innovative Regenerative Medicine

  • Activity Reports
    • Activity Report List
    • Supporting Industries Committee
    • Cell and Gene Therapy Products(CGTP’s) Committee
    • Specific Processed Cells Committee
    • Standardization Committee
    • Public Affairs Committee
    • International Affairs Committee
    • Education Implementation Committee
    • Venture Establishment / Promotion Committee
    • Committee to Standardize Foundation for Cell Characterization and Cell Production
    • ISO/TC 276 Japan Mirror Committee
    • Committee for Non-Clinical Safety Evaluation of Pluripotent Stem Cell-derived Product
    • Event report
  • Ancillary Materials
  • Public Comment​
  • National and international regenerative medicine trends
  • About FIRM​
    • About FIRM​
    • A message from ​ the Chairperson
    • Company Info​
    • Organization Chart
    • Access
    • Overview​ FIRM History​
    • FIRM VISION 2025
    • Member Introduction
    • FIRM Brochure​
    • FIRM Startup / Private Company Map
  • Contact Us
  • FIRM mark certification
FIRM mark certification
    FIRM mark certification
  • APACRM
Member Introduction
  • EN
  • JP
  • Sitemap​
  • Activity Report List
  • Supporting Industries Committee
  • Cell and Gene Therapy Products(CGTP’s) Committee
  • Specific Processed Cells Committee
  • Standardization Committee
  • Public Affairs Committee
  • International Affairs Committee
  • Education Implementation Committee
  • Venture Establishment / Promotion Committee
  • Committee to Standardize Foundation for Cell Characterization and Cell Production
  • ISO/TC 276 Japan Mirror Committee
  • Committee for Non-Clinical Safety Evaluation of Pluripotent Stem Cell-derived Product
  • Event report
  • About FIRM​
  • A message from ​ the Chairperson
  • Company Info​
  • Organization Chart
  • Access
  • Overview​ FIRM History​
  • FIRM VISION 2025
  • Member Introduction
  • FIRM Brochure​
  • FIRM Startup / Private Company Map
    FIRM mark certification
  • APACRM
Member
Introduction
Member
only
English | FIRM Startup / Private Company Map | OthersClinical Trial (Phase I)

Others
Clinical Trial (Phase I)

Release date: 2023/10/4

■ PDF Download

  • Antigen specific iTs (induced T cells with suppressing function) cell therapy / JUNTEN BIO Co., Ltd.
  • Fibroblast-Catheter Therapy: Redefining Heart Failure Treatment / Metcela Inc.

  • Sitemap​

(c) Forum for Innovative Regenerative Medicine

Pagetop